SHA:603896 Revenue

In the year 2025, Zhejiang Shouxiangu Pharmaceutical had annual revenue of 640.18M CNY, down -7.45%. Zhejiang Shouxiangu Pharmaceutical had revenue of 210.04M in the quarter ending December 31, 2025, a decrease of -7.04%.

Revenue

640.18M

Revenue Growth

-9.21%

P/S Ratio

5.41

Revenue / Employee

572.61K

Employees

1,118

Market Cap

3.46B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	640.18M	-51.50M	-7.45%
Dec 31, 2024	691.68M	-92.66M	-11.81%
Dec 31, 2023	784.35M	-44.72M	-5.39%
Dec 31, 2022	829.07M	61.93M	8.07%
Dec 31, 2021	767.14M	131.09M	20.61%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shanghai Shen Lian Biomedical	288.27M
Zhejiang Wecome Pharmaceutical Company	131.67M
Shanghai Serum Bio-Technology	197.68M
Qingdao Vland Biotech INC.	1.37B
Guanhao Biotech	387.75M
Baolingbao Biology	2.81B
Novoprotein Scientific	151.51M
Beijing Kawin Technology Share-Holding	1.30B

Revenue Rankings